Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers, 1st ed. 2020
Diagnostics and Therapeutic Advances in GI Malignancies Series

Language: English
Cover of the book Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers

Subjects for Recent Advancements in Biomarkers and Early Detection of...

105.49 €

In Print (Delivery period: 15 days).

Add to cartAdd to cart
Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers
Publication date:
231 p. · 15.5x23.5 cm · Paperback

105.49 €

In Print (Delivery period: 15 days).

Add to cartAdd to cart
Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers
Publication date:
Support: Print on demand

This book describes various novel biomarkers for the early diagnosis of gastrointestinal (GI) cancers. It also highlights recent advances in understanding the role of molecular markers and biomarkers, such as volatile biomarkers, serum biomarkers, predictive and prognostic molecular markers for the early detection of GI cancers. Further, it discusses novel biomarkers, including circulating microRNAs, serum microRNA and plasma microRNA in GI cancer.

The book presents breakthrough technologies like ultra-sensitive nano-chips, nanosensors, nanodevices, biosensors, electrochemical biosensors, optical biosensors, DNA biosensors, synthetic biology devices, and 'omics' technologies for the early diagnosis of gastrointestinal cancer. In addition it examines the potential of genome-wide association studies, big data analytics, computation biology, systems biology, and nanotechnology for early diagnostics and therapeutics for gastrointestinal cancer, with a focus on personalized cancertreatment.

The book is a valuable source for researchers and clinicians engaged in detection and diagnosis of gastrointestinal cancers.

Chapter 1. Potential Role of Biomarkers, Biosensors, Technologies and Computational Methods in Early Detection of Gastrointestinal Cancer.- Chapter 2. Biomarkers as the Promising Tools for Early Detection of Gastrointestinal Cancer.- Chapter 3. Development and Evaluation of Biomarkers for Early Detection of Cancer.- Chapter 4. Prognostic Molecular Markers for Gastrointestitinal cancer.- Chapter 5. Metabolic Markers for Early Detection of Gastrointestinal Cancer.- Chapter 6. Current Status of MicroRNA-based Biomarkers for Gastric Cancer.- Chapter 7.  Genetic Susceptibility Markers of Gastrointestinal Cancer.- Chapter 8. Approaches For Early Detection Of Gastrointestinal Cancer.- Chapter 9. Biosensors and its Applications for Early Detection of Gastrointestitinal Cancer.-  Chapter 10. Application of Nanotechnology in Early Detection of Gastrointestinal Cancer.- Chapter 11. Genetic Marker Identification for the Detection of Early-Onset Gastrointestitinal Cancer Through Genome Wide Association Studies.- Chapter 12. Big Data Analytics to Discover Diagnostics and Therapeutics for Gastrointestitinal Cancer.- Chapter 13. System Biology Approach for Early Prognosis of Gastrointestinal Cancer.


Dr. Pallaval Veera Bramhachari is currently Head of the Department of Biotechnology at Krishna University, India. He has served as a Postdoctoral Research Scientist at the Bacterial Pathogenesis Laboratory, Queensland Institute of Medical Research (QIMR), Australia, and DBT Postdoctoral Fellow at the Department of Microbiology and Cell Biology, Indian Institute of Science (IIsc), Bangalore. He holds a Ph.D. in Microbiology from Goa University, India. His major research focuses on applied microbiology and cell biology research, including biochemical mechanism of bacterial-biofilm formations, structure-function relationship of bacterial rhamnolipids, and basic and translational cancer research. He has published more than 115 research articles in leading peer-reviewed international journals, and 3 international books and has presented 47 abstracts at various national and international conferences. He has served as an editorial board member and reviewer for a number of national andinternational journals. He is a member of several international scientific societies and organizations, most importantly, Indian Science Congress & Society of Biological Chemists, India. He has received a number of various prestigious awards, notably, AP State Best Scientist Award 2017, DST SERB Young Scientist Award (2011) and nominated as an Associate Fellow of Andhra Pradesh Academy of Sciences (APAS) for the year 2016.

Dr. Neelapu Nageswara Rao Reddy is currently an Assistant Professor at the Department of Biochemistry and Bioinformatics, Institute of Science, Gandhi Institute of Technology and Management (GITAM) (deemed university), India. He obtained his Master’s in Life Science from Pondicherry Central University, and Ph.D. in Evolutionary Bioinformatics from Andhra University, Visakhapatnam, India. His research interests include bioinformatics, cancer, and fungal biology with specialization in drug target discovery, HLA-based peptide vaccine design, genome analysis, phylogeny

Summarizes the recent advances in potential cancer diagnostic markers in gastrointestinal cancers Examines the molecular markers, metabolic markers, circulatory biomarkers, and genetic susceptibility markers in GI cancers Discusses the role of GWAS, big data analytics, computation biology, and systems biology in identifying novel biomarkers Reviews the use of nanosensors, and electrochemical, optical and DNA biosensors for analyzing markers of GI cancer